| The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study (NCT04700527) | UNC Lineberger Comprehensive Cancer Center | 2023-12-15 |
| Fluorescent Navigation Technology in Radical Resection of Pancreatic Cancer (NCT06168552) | Zhejiang University | 2023-12-15 |
| Phase 1, SAD/MAD of Verasone™ Administered by Sinonasal Irrigation in Healthy Participants (NCT06147921) | Diceros Therapeutics | 2023-12-15 |
| Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations (NCT06043713) | Fred Hutchinson Cancer Center | 2023-12-15 |
| A Study of the Efficacy of Troxerutin in Preventing Thrombotic Events in COVID-19 Patients (NCT06355258) | Westlake University | 2023-12-15 |
| A Study to Determine the Effect of KP-001 on Metformin and Midazolam Pharmacokinetics and the Effect of Clarithromycin on KP-001 Pharmacokinetics in Healthy Adult Participants (NCT06227832) | Kaken Pharmaceutical | 2023-12-15 |
| Safety and Preliminary Efficacy of Aleeto in Amyotrophic Lateral Sclerosis (NCT06181526) | Beijing Tiantan Hospital | 2023-12-15 |
| Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT03735589) | Roswell Park Cancer Institute | 2023-12-15 |
| Study to Evaluate the Fecal Microbiota Transplantation (FMT) in the Treatment of Ulcerative Colitis (NCT05786404) | The University of Texas Health Science Center, Houston | 2023-12-15 |
| A Study of JNJ-87890387 for Advanced Solid Tumors (NCT06178614) | Janssen Research & Development, LLC | 2023-12-14 |
| Phase 1 Trial of AZD6422 in CLDN18.2+ GI Tumors (NCT05981235) | Peking University | 2023-12-14 |
| A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma (NCT06084884) | AstraZeneca | 2023-12-14 |
| The Safety, Tolerability, Pharmacokinetics and Food Effects of SHEN211 Tablet in Healthy Subjects (NCT06214858) | JKT Biopharma Co., Ltd. | 2023-12-14 |
| AMPK-activation by Metformin in FSGS: AMP-FSGS (NCT06090227) | Yale University | 2023-12-14 |
| Pharmacokinetics of Fixed-Dose Combination Tablet of Bemnifosbuvir and Ruzasvir (NCT06204679) | Atea Pharmaceuticals, Inc. | 2023-12-14 |
| Casea S Contraceptive Implants (Casea S) Trial (NCT05174884) | FHI 360 | 2023-12-13 |
| An Early Stage Study to Evaluate Oba01 for Injection in Patients With DR5 Positive LA/mNSCLC (NCT06083870) | Lu Shun | 2023-12-13 |
| A Mass Balance Study of [14C]ABSK021 (NCT06186583) | Abbisko Therapeutics Co, Ltd | 2023-12-13 |
| Bioequivalence Study of 2 Sizes of SHR4640 Tablets Orally in Healthy Subjects (NCT06168929) | Jiangsu HengRui Medicine Co., Ltd. | 2023-12-13 |
| TGRX-326 Pharmacokinetic Food Effect Bioavailability Study (NCT06304805) | Shenzhen TargetRx Co., Ltd. | 2023-12-13 |
| A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849 (NCT05761223) | 1ST Biotherapeutics, Inc. | 2023-12-13 |
| Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes (NCT06105931) | Yale University | 2023-12-13 |
| A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza (NCT06179446) | Pfizer | 2023-12-13 |
| This is an Open Label, Two-part, Multicenter, Phase I Trial to Investigate the Safety, Tolerability, and PK of KGX101 Monotherapy and Combination Therapy With Envafolimab in Patients With Advanced or Metastatic Solid Tumors. (NCT06074497) | Kangabio AUSTRALIA LTD PTY | 2023-12-13 |
| Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer (NCT04997993) | Deborah Doroshow | 2023-12-13 |
| Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab (NCT06011109) | Aveta Biomics, Inc. | 2023-12-13 |
| First-in-human Safety and Immunogenicity Study of SCB-1019 and SCB-1019T in Healthy Adults (NCT06194318) | Clover Biopharmaceuticals AUS Pty | 2023-12-13 |
| Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis (NCT06154447) | Vertex Pharmaceuticals Incorporated | 2023-12-12 |
| A Study to Evaluate the Safety, Tolerance, Pharmacokinetics, and Preliminary Antineoplastic Activity of AK132 in Advanced Malignant Solid Tumor (NCT06166472) | Akeso | 2023-12-12 |
| Safety and Efficacy of RRG001 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD) (NCT06141460) | Shanghai Refreshgene Technology Co., Ltd. | 2023-12-12 |
| Clinical Study of Mitoxantrone Liposome and Azacitidine in the Treatment of R/R AITL (NCT06224842) | Huijing Wu | 2023-12-12 |
| Advair HFA in Healthy and HAPE Predisposed Subjects (NCT06040268) | University of Colorado, Denver | 2023-12-12 |
| A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF) (NCT06122831) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-12-12 |
| HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors (NCT05861895) | HighField Biopharmaceuticals Corporation | 2023-12-12 |
| Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma (NCT05821231) | Institut Claudius Regaud | 2023-12-12 |
| Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1 (NCT06204809) | PepGen Inc | 2023-12-12 |
| A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants With Relapsed or Refractory Multiple Myeloma (NCT06055075) | Hoffmann-La Roche | 2023-12-12 |
| A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD (NCT07116889) | Generate Biomedicines | 2023-12-12 |
| A Study in Healthy Men to Test How BI 1291583 is Taken up by the Body (NCT06166992) | Boehringer Ingelheim | 2023-12-12 |
| Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies (NCT06028074) | Georgiamune Inc | 2023-12-12 |
| CLN-617 Alone and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors (NCT06035744) | Cullinan Therapeutics Inc. | 2023-12-12 |
| Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study) (NCT06152237) | Taysha Gene Therapies, Inc. | 2023-12-12 |
| A Study Comparing Pharmacokinetic and Safety of QL2107 and Keytruda® (Marketed in China and the United States) in Healthy Adults (NCT06173011) | Qilu Pharmaceutical Co., Ltd. | 2023-12-12 |
| Effects Multimodal Mind and Body Approach for MCI (NCT06814483) | Massachusetts General Hospital | 2023-12-11 |
| A Study to Investigate the Safety of GSK4024484 in Healthy Adult Participants (NCT06171113) | GlaxoSmithKline | 2023-12-11 |
| Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell Transplant (NCT05984199) | Vor Biopharma | 2023-12-11 |
| Pharmacological Enhancement of Glymphatic Function in Humans (NCT07432997) | Applied Cognition | 2023-12-11 |
| ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC (NCT05682443) | OncoC4, Inc. | 2023-12-11 |
| A Study Evaluating Single-agent Inavolisib, Inavolisib Plus Atezolizumab in PIK3CA-Mutated Cancers (NCT06496568) | Hoffmann-La Roche | 2023-12-11 |
| A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors (NCT06253130) | Eikon Therapeutics | 2023-12-11 |
| Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage (NCT05939167) | Cell Energy Life Sciences Group Co. LTD | 2023-12-10 |
| Evaluation of Bone Preservation After Molar Extraction Using Photobiomodulation Combined With Biomaterial Grafting (NCT06164626) | University of Nove de Julho | 2023-12-10 |
| To Evaluate The Safety and Initial Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome (NCT06038916) | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2023-12-09 |
| Single and Multiple Ascending Oral Doses of Avenanthramide (NCT06101784) | Montreal Heart Institute | 2023-12-09 |
| A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas (NCT06028373) | Antengene Biologics Limited | 2023-12-08 |
| KF2022#3-trial: Effect of Tea and Cola Beverage on Absorption of Risperidone Oral Solution (NCT06218979) | Helsinki University Central Hospital | 2023-12-08 |
| A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carcinoma (NCT06157827) | Nanjing Leads Biolabs Co.,Ltd | 2023-12-08 |
| Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors (NCT06065059) | Tango Therapeutics, Inc. | 2023-12-08 |
| A Study to Evaluate the STI-8591 in Subjects With Advanced Acute Myeloid Leukemia (AML) (NCT05947344) | Zhejiang ACEA Pharmaceutical Co. Ltd. | 2023-12-08 |
| Mass Balance Study of [14C] D-1553 in Chinese Healthy Adult Male Subjects (NCT06233916) | InventisBio Co., Ltd | 2023-12-08 |
| CAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in Vivo Imaging and Molecular Monitoring Study (NCT05666700) | Peter MacCallum Cancer Centre, Australia | 2023-12-08 |
| Study of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A) (NCT06181136) | Denali Therapeutics Inc. | 2023-12-07 |
| A Study of LY3971297 in Healthy Participants (NCT06148272) | Eli Lilly and Company | 2023-12-07 |
| CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia (NCT05672147) | City of Hope Medical Center | 2023-12-07 |
| Clinical Study of SM3321 With Solid Tumors (NCT06087770) | Beijing StarMab Biomed Technology Ltd | 2023-12-07 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes (NCT06305351) | Kallyope Inc. | 2023-12-07 |
| A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B (NCT06150014) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-12-07 |
| A Multiple Dose Study of LY3209590 in Participants With Type 2 Diabetes (NCT06169982) | Eli Lilly and Company | 2023-12-07 |
| Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma (NCT06211335) | University of California, Davis | 2023-12-07 |
| Safety Study of Inhaled Carbon Monoxide to Treat Pneumonia and Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS) (NCT04870125) | Brigham and Women's Hospital | 2023-12-06 |
| A Study to See How Safe and Tolerable Different Doses of REGN13335 Are When Administered Intravenously (IV) or Subcutaneously (SC) to Healthy Adult Participants (NCT06137482) | Regeneron Pharmaceuticals | 2023-12-06 |
| A Study of JNJ-87801493 in Combination With T-Cell Engagers in Participants With B-cell Non-Hodgkin Lymphoid (NHLs) Cancer (NCT06139406) | Janssen Research & Development, LLC | 2023-12-06 |
| First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients (NCT05964361) | University Hospital, Antwerp | 2023-12-06 |
| To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in Healthy Subjects (NCT06216041) | Changchun Intellicrown Pharmaceutical Co. LTD | 2023-12-06 |
| Safety and Tolerability of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars (NCT06210919) | CellinCells | 2023-12-06 |
| Oral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes (NCT05782127) | Groupe Francophone des Myelodysplasies | 2023-12-06 |
| A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors (NCT06139211) | Shanghai Junshi Bioscience Co., Ltd. | 2023-12-06 |
| A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above) (NCT06056050) | CanSino Biologics Inc. | 2023-12-06 |
| Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer (NCT05722327) | M.D. Anderson Cancer Center | 2023-12-06 |
| A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus (NCT06056024) | Boehringer Ingelheim | 2023-12-06 |
| Phase 1 Hepatic Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride (NCT06176716) | Ahon Pharmaceutical Co., Ltd. | 2023-12-06 |
| A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients (NCT06521931) | Chongqing Peg-Bio Biopharm Co., Ltd. | 2023-12-06 |
| Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD) (NCT05769153) | Alcon Research | 2023-12-06 |
| Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study (NCT06190509) | LimmaTech Biologics AG | 2023-12-06 |
| A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer (NCT06184035) | Spago Nanomedical AB | 2023-12-06 |
| A PhaseⅠStudy of ONO-7475 in Combination With ONO-4538 and Gemcitabine Plus Nab-paclitaxel (GnP), the Standard of Care, and ONO-7475 in Combination With GnP in Patients With Pancreatic Cancer (NCT06532331) | Ono Pharmaceutical Co., Ltd. | 2023-12-06 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Oral Administration of AJH-2947 in Healthy Korean and/or Caucasian Adult Male Subjects (NCT06155487) | JMackem Co., Ltd | 2023-12-05 |
| A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma (NCT05908786) | Hoffmann-La Roche | 2023-12-05 |
| Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK31679 in Healthy Adult Male Volunteers. (NCT06258746) | Xizang Haisco Pharmaceutical Co., Ltd | 2023-12-05 |
| Adaptive Training Recommendations for Improved Physical Performance (NCT06145152) | The Swedish School of Sport and Health Sciences | 2023-12-05 |
| A Single and Multiple Ascending Dose Study of LAD603 in Healthy Subjects (NCT06200597) | Almirall, S.A. | 2023-12-05 |
| R-5280 in Newly Diagnosed Patients With Type 1 Diabetes (NCT06057454) | Rise Therapeutics LLC | 2023-12-05 |
| A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors (NCT06188520) | AstraZeneca | 2023-12-05 |
| UTAA06 Injection for Treatment of Advanced Malignant Solid Tumors (NCT06372236) | Peking University | 2023-12-05 |
| Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Subjects (NCT06164834) | HK inno.N Corporation | 2023-12-05 |
| AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma (NCT06106945) | AstraZeneca | 2023-12-05 |
| A First-In-Human Study of LY3839840 in Healthy Participants (NCT06153355) | Eli Lilly and Company | 2023-12-04 |
| A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms (NCT06034002) | Incyte Corporation | 2023-12-04 |
| A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer (NCT06005740) | TORL Biotherapeutics, LLC | 2023-12-04 |
| CampETEC Hyperimmune Bovine Colostrum (HBC) (NCT06122870) | Johns Hopkins Bloomberg School of Public Health | 2023-12-04 |